Jongwook Cho et al and the Hyoung‑Ihl Kim group from Gwangju Institute of Science and Technology (GIST) in Korea published Translational Stroke Research. They used NeuroNexus A1x16-10mm-100-177-A16 probes to measure single-unit activity before and after a single dose of clozapine in a rat model of stroke. Recordings in the sensory-parietal cortex confirmed a significant and persistent increase in firing rate associated with DREADD-based chemogenetic neuromodulation. Results showing increases in markers of neural plasticity support clozapine as a viable option for post-stroke recovery treatment.